Dyne Therapeutics vs Viking Therapeutics: 2026 Buy Guide
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
Articles — Page 506
SoFi Stock Back Around: Is the Bull Case Here for Real?
SoFi stock has dipped back toward the $18 area, prompting questions about a long-awaited recovery. This guide breaks ...
Worried About Stock Market? A Rock-Solid Dividend Stock
If you’re worried about stock market volatility, a proven dividend stock can be your anchor. This guide explains why ...
Advanced Micro Devices Stock Slipped Friday: What to Know
Friday brought a dip in advanced micro devices stock as AI market optimism cooled. This guide breaks down the drivers...
Bristol Myers Squibb Johnson: Which Stock to Buy in 2026?
Choosing between two healthcare giants comes down to balance: steady income or longer-term growth. This guide dives i...
Micron Just Delivered Great News for AI and Chip Investors
A renewed memory cycle could reshape profits for big chip players. This deep dive explains why Micron's latest update...
Stock Market Crash Coming: One Vanguard ETF to Buy Now
When uncertainty rises, smart investors turn to simple, high-quality solutions. This guide explains why the Vanguard ...
Which Better Global ETF for Core Global Exposure: VT Versus SPGM
Choosing a global ETF means balancing cost, diversification, and performance. This guide compares Vanguard VT and Sta...
Crypto Firms Race to Lock Clarity Act Rules Before Recess
As the Senate nears its August recess, crypto firms race lock on the CLARITY Act, pushing for a floor vote before law...
VA Updates Appraisal Rules, Adjusts Fees in Regions
The Department of Veterans Affairs rolled out changes to its home loan appraisal process, removing outdated rules and...
Billion Stocks About Market: Rebalance Window Opens
A two-day pension fund rebalance could move about $30 billion of U.S. stocks, posing near-term volatility but often a...
Wall Street Ratings Oracle Signal: 47% Upside Looms with AI Push
Oracle's AI strategy is under scrutiny as earnings shed light on backlog and cash needs. We see roughly 46-47% upside...